Genus (LSE:GNS) ROCE %: 12.43% (As of Dec. 2025)


LSE:GNS Genus PLC LSE:GNS
75 GF Score
Price £21.58
GF Value £20.62
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is Genus ROCE %?

Genus LSE:GNS +1.22% 75 ROCE % is 12.43% as of Dec. 2025. GuruFocus rates LSE:GNS with a GF Score™ of 75/100 and a GF Value™ of £20.62 (Fairly Valued). The stock has 5 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Genus's annualized ROCE % for the quarter that ended in Dec. 2025 was 12.43%.

Genus  (LSE:GNS) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Genus ROCE % Related Terms

Genus ROCE % Historical Data

* Premium members only.

The historical data trend for Genus's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Genus ROCE % Chart

Genus Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8.41 6.87 6.37 3.24 6.11

Genus Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.69 0.45 3.34 8.62 12.43
LSE:GNS
75GF Score
Genus PLC LSE:GNS
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Genus ROCE % Calculation

Genus's annualized ROCE % for the fiscal year that ended in Jun. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Jun. 2025 )  (A: Jun. 2024 )(A: Jun. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Jun. 2025 )  (A: Jun. 2024 )(A: Jun. 2025 )
=49/( ( (987.8 - 150.6) + (899 - 131.3) )/ 2 )
=49/( (837.2+767.7)/ 2 )
=49/802.45
=6.11 %

Genus's ROCE % of for the quarter that ended in Dec. 2025 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Dec. 2025 )  (Q: Jun. 2025 )(Q: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Dec. 2025 )  (Q: Jun. 2025 )(Q: Dec. 2025 )
=96.6/( ( (899 - 131.3) + (921.3 - 134.8) )/ 2 )
=96.6/( ( 767.7 + 786.5 )/ 2 )
=96.6/777.1
=12.43 %

(1) Note: The EBIT data used here is two times the semi-annual (Dec. 2025) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 12.43% mean?
Genus (LSE:GNS) has a ROCE % of 12.43% as of Dec. 2025.
Is Genus' ROCE % too high?
Genus' current ROCE % is 12.43%. Overall, Genus has a GF Score™ of 75/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Genus' ROCE % compare to VRTX and REGN?
Genus' ROCE % of 12.43% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Biotechnology company?
A good ROCE % depends on the Biotechnology industry context. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. Genus's current ROCE % is 12.43%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Genus stock overvalued right now?
Based on GuruFocus' analysis, Genus (LSE:GNS) is currently considered Fairly Valued. The stock's GF Value™ is £20.62, compared to a current price of £21.58 — trading 4.7% above its estimated fair value. The current ROCE % is 12.43%. Genus' overall GF Score™ is 75/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Genus (LSE:GNS), the current ROCE % is 12.43% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Genus (LSE:GNS) Overvalued in 2026?

Based on GuruFocus' analysis, Genus stock appears to be overvalued. The current stock price of £21.58 is trading 4.7% above its estimated GF Value™ of £20.62. GuruFocus considers Genus to be Fairly Valued.

Key valuation signals for LSE:GNS:

  • ROCE %: 12.43%
  • GF Value™: £20.62 vs. price of £21.58 (4.7% above fair value)
  • GF Score™: 75/100 with 5 warning signs

No single metric tells the full story. See the LSE:GNS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Genus Business Description

Address Matrix House, Basing View, Basingstoke, Hampshire, GBR, RG21 4FF
Genus PLC is an animal genetics company focused on improving cattle and pig populations to support sustainable food production. The company operates through two main business units: one providing bovine genetics mainly for dairy and beef cattle, and the other offering porcine genetics for pork production. Genus develops genetically superior breeding animals using scientific techniques. It generates revenue by selling genetics, including semen and embryos, as well as through related services under multi-year royalty agreements. The principal activities of each segment are: (a) Genus PIC porcine sales business, (b) Genus ABS: bovine sales business, and (c) Genus Research and Development: spending on research and development.
75GF Score

Get the complete analysis for LSE:GNS

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

£21.58
Price
£20.62
GF Value